Targeting mitochondrial enzyme may reduce chemotherapy drug’s cardiac side effects

Massachusetts General Hospital (MGH) investigators have identified two compounds that appear, in cellular and animal models, to block the cardiac damage caused by the important chemotherapy drug doxorubicin. Their report in the Dec. 10 issue of Science Translational Medicine indicates that…

Source:Targeting mitochondrial enzyme may reduce chemotherapy drug’s cardiac side effects